Literature DB >> 18981996

Granulocyte-monocyte apheresis for the treatment of ulcerative colitis--is this the end of the road?

Subrata Ghosh1, Gilaad Kaplan, Remo Panaccione.   

Abstract

Entities:  

Year:  2008        PMID： 18981996     DOI： 10.1038/ncpgasthep1299

Source DB:  PubMed          Journal:  Nat Clin Pract Gastroenterol Hepatol        ISSN： 1743-4378


× No keyword cloud information.
  7 in total

1.  A pilot open-labeled prospective randomized study between weekly and intensive treatment of granulocyte and monocyte adsorption apheresis for active ulcerative colitis.

Authors:  Atsushi Sakuraba; Toshiro Sato; Makoto Naganuma; Yuichi Morohoshi; Katsuyoshi Matsuoka; Nagamu Inoue; Hiromasa Takaishi; Haruhiko Ogata; Yasushi Iwao; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2008-02-24       Impact factor: 7.527

2.  A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.

Authors:  Bruce E Sands; William J Sandborn; Brian Feagan; Robert Löfberg; Toshifumi Hibi; Tao Wang; Lisa-Marie Gustofson; Cindy J Wong; Margaret K Vandervoort; Stephen Hanauer
Journal:  Gastroenterology       Date:  2008-04-25       Impact factor: 22.682

3.  Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.

Authors:  Koji Sawada; Kazuo Kusugami; Yasuo Suzuki; Tadao Bamba; Akihiro Munakata; Toshifumi Hibi; Takashi Shimoyama
Journal:  Am J Gastroenterol       Date:  2005-06       Impact factor: 10.864

4.  Granulocyte, monocyte/macrophage apheresis for inflammatory bowel disease: the first 100 patients treated in Scandinavia.

Authors:  Tryggve Ljung; Ole Østergaard Thomsen; Morten Vatn; Per Karlén; Lars Norman Karlsen; Curt Tysk; Stefan U Nilsson; Anders Kilander; Rolf Gillberg; Olof Grip; Stefan Lindgren; Ragnar Befrits; Robert Löfberg
Journal:  Scand J Gastroenterol       Date:  2007-02       Impact factor: 2.423

5.  Granulocyte and monocyte adsorptive apheresis in the treatment of active distal ulcerative colitis: a prospective, pilot study.

Authors:  T Yamamoto; S Umegae; T Kitagawa; Y Yasuda; Y Yamada; D Takahashi; M Mukumoto; N Nishimura; K Yasue; K Matsumoto
Journal:  Aliment Pharmacol Ther       Date:  2004-10-01       Impact factor: 8.171

6.  Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse.

Authors:  Laurence Maiden; Ken Takeuchi; Rosie Baur; Ingi Bjarnason; John O'Donohue; Ian Forgacs; Guy Chung-Faye; Jeremy Sanderson; Ingvar Bjarnason
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

7.  Granulocytapheresis is useful as an alternative therapy in patients with steroid-refractory or -dependent ulcerative colitis.

Authors:  Makoto Naganuma; Shinsuke Funakoshi; Atsushi Sakuraba; Hanae Takagi; Nagamu Inoue; Haruhiko Ogata; Yasushi Iwao; Hiromasa Ishi; Toshifumi Hibi
Journal:  Inflamm Bowel Dis       Date:  2004-05       Impact factor: 5.325
  7 in total
  1 in total

1.  Preliminary studies for the development of a second generation granulocytapheresis (G-CAP) column.

Authors:  Hiroshi Miyamoto; Yoichi Sugita; Tadashi Motomura; Kazuhide Ohta; Yukihiko Nosé
Journal:  J Artif Organs       Date:  2010-04-03       Impact factor: 1.731
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.